— Know what they know.
Not Investment Advice
Also trades as: EKTA-B.ST (STO) · $vol 7M · 0O5H.IL (IOB) · $vol 5M · EKTAF (OTC) · $vol 0M

EKTAY OTC

Elekta AB (publ)
1W: +0.0% 1M: -5.6% 3M: -4.5% YTD: -16.7% 1Y: +2.0% 3Y: -19.6% 5Y: -52.9%
$5.09
-0.04 (-0.78%)
 
Weekly Expected Move ±4.1%
$5 $5 $5 $5 $6
OTC · Healthcare · Medical - Devices · Tech Score Sell · Power 41 · $1.9B mcap · 311M float · 0.0011% daily turnover · Short 31% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$1.9B
52W Range4.35-6.93
Volume669
Avg Volume3,405
Beta1.08
Dividend$0.25
Analyst Ratings
0 Buy 1 Hold 0 Sell
Consensus Hold
Company Info
CEOJakob Just-Bomholt
Employees4,102
SectorHealthcare
IndustryMedical - Devices
IPO Date2009-03-03
Websiteelekta.com
Hagaplan 4
Stockholm, SD 113 68
SE
46 8 58 72 54 00
About Elekta AB (publ)

Elekta AB (publ) is a global medical technology company dedicated to developing and delivering advanced clinical solutions for the treatment of cancer and brain disorders. Its comprehensive portfolio includes innovative radiotherapy systems such as the Elekta Unity MR-Linac, the Elekta Harmony linear accelerator, Elekta Infinity for diverse patient radiotherapy requirements, and the Elekta Synergy digital accelerator for advanced image-guided radiation therapy. Specific solutions like Versa HD are available for managing brain metastases. The company also supplies crucial treatment management software, automated and integrated quality assurance tools, and hardware and software for motion management. Further augmenting its oncology offerings, Elekta provides MOSAIQ Plaza for integrated multidisciplinary cancer care and Elekta Axis Cloud for managed hosting. Within brachytherapy, key products include the image-guided Elekta Studio, the mobile ImagingRing CT scanner, Oncentra Brachy for streamlining repetitive tasks, the Elekta Flexitron afterloader for precise workflow execution, and specialized applicators like Venezia and Geneva for cervical cancer treatment. For neurological conditions, Elekta offers a suite of advanced radiosurgery and neurosurgery solutions. This includes the Leksell Gamma Knife series – Icon for personalized radiation treatment, Perfexion for neurosurgical applications, and Lightning for accelerated procedures. Its neurosurgery product line features the Leksell Vantage Stereotactic System for intracranial interventions and the Leksell Stereotactic System for minimally invasive stereotactic neurosurgery. Founded in 1972, Elekta maintains its corporate headquarters in Stockholm, Sweden.

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms